Imaging of Gastrointestinal Neuroendocrine Tumors

Clinical Endocrine Oncology: Second Edition

Volumn , Issue , 2009, Pages 443-454

  Scarsbrook, Andrew F ^a   Phillips, Rachel R ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

CT; Functional imaging; Imaging of gicarcinoid tumors; Imaging of islet cell tumors; Imaging of metastatic carcinoid tumors; MRI; Ultrasound

Indexed keywords

EID: 63749103178     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444300222.ch58     Document Type: Chapter

References (20)

1. Oberg K, Astrup L, Eriksson B, et al. Guidelines for the management of gastroenteropancreatic neurondocrine tumours. Acta Oncol. 2004; 43:617-625.
2. Solcia E, Kloppel G, Sobin LH. Histological typing of endocrine tumours, second edition. In International Histological Classification of Tumours. Berlin: World Health Organization, Springer, 2000.
3. Plockinger U, Rindi G, Arnold R, et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society. Neuroendocrinology 2004; 80:394-424.
4. Gore RM, Berlin JW, Mehta UK, et al. GI carcinoid tumours: appearance of the primary and detecting metastases. Best Pract. Res. Clin. Endocrinol. Metab. 2005; 19:245-263.
5. Delle Fare G, Capurso G, Annibale B, et al. Gastric neuroendocrine tumors. Neuroendocrinology 2004;80(Suppl 1):16-19.
6. Levy AD, Taylor LD, Abbott RM, et al. Duodenal carcinoids: imaging features with clinical-pathologic comparison. Radiology 2005; 237:967-972.
7. Kvols L. Carcinoids of the appendix. Neuroendocrinology 2004; 80(Suppl 1):33-34.
8. Pfennenberg AC, Eschmann SM, Hozer M, et al. Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms. Eur. J. Nucl. Med. Molec. Imaging 2003; 30:835-843.
9. Kaltsas G, Korbonits M, Heintz E, et al. Comparison of somatostatin analogue and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumours. J. Clin. Endocrinol. Metab. 2001; 86:895-902.
10. Pacak K, Eisnehofer G, Goldstein DS. Functional imaging of endocrine tumors: role of positron emission tomography. Endocr. Rev. 2004; 25:568-580.
11. Power N, Reznek RH. Imaging islet cell tumours. Imaging 2002; 14:147-159.
12. Ricke J, Klose K-J, Mignon M, et al. Standardisation of imaging in neuroendocrine tumours; results of a European Delphi process. Eur. J. Radiol. 2001; 37:8-17.
13. Anderson MA, Carpenter S, Thompson NW, et al. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumours of the pancreas. Am. J. Gastroenterol. 2000; 95:2271-2277.
14. Noone TC, Hosey J, Firat Z, et al. Imaging and localization of islet cell tumours of the pancreas on CT and MR. Best Pract. Res. Clin. Endocrinol. Metab. 2005; 19:195-211.
15. Owen NJ, Sohaib SAA, Peppercorn PD, et al. MRI of pancreatic neuroendocrine tumours. Br. J. Radiol. 2001; 74:968-973.
16. Reubi JC. Somatostatin and other peptide receptors as tools for tumour diagnosis and treatment. Neuroendocrinology 2004; 80:51-56.
17. Debray MP, Geoffroy O, Laissy JP, et al. Imaging appearances of metastases from neuroendocrine tumours of the pancreas. Br. J. Radiol. 2001; 74:1065-1070.
18. Ramage JK, Davies AHG, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine including carcinoid tumours. Gut 2005;54(Suppl IV):iv1-iv16.
19. Kaltsas GA, Besser GM, Grossman A. The diagnosis and medical management of advanced neuroendocrine tumours. Endocr. Rev. 2004; 25:458-511.
20. Guidelines from Neuroendocrine Tumors, National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology, v.1.2003.